相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。β-Hydroxybutyrate and Medium-Chain Fatty Acids are Metabolized by Different Cell Types in Mouse Cerebral Cortex Slices
Jens Andersen et al.
NEUROCHEMICAL RESEARCH (2023)
Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research
Marcia N. Gordon et al.
ALZHEIMERS & DEMENTIA (2022)
Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome
Andrea Dressing et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
Philipp T. Meyer et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell et al.
BIOCHEMICAL JOURNAL (2022)
Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series
Aurelie Morand et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review
Chen Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Natalia M. Lyra e Silva et al.
NEUROPHARMACOLOGY (2022)
2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
Antoine Verger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study
Peter Liptak et al.
METABOLITES (2022)
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients
Anna Lisa Martini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection*
Gerard J. Nuovo et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2022)
Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19
Harmke B. Duindam et al.
BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2022)
Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double-blind, placebo-controlled, crossover study, with an open-label extension
Angela G. G. Juby et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)
18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?
E. Guedj et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Frontal encephalopathy related to hyperinflammation in COVID-19
Ilaria Cani et al.
JOURNAL OF NEUROLOGY (2021)
Assessment and characterisation of post-COVID-19 manifestations
Marwa Kamal et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies
M. V. Putilina et al.
Neuroscience and Behavioral Physiology (2021)
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
Patrycja Puchalska et al.
Annual Review of Nutrition (2021)
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study
Aurelie Kas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
18F-FDG brain PET hypometabolism in patients with long COVID
E. Guedj et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment.
Etienne Myette-Cote et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2021)
Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study
Cesar Fernandez-de-Las-Penas et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Selective Neuronal Mitochondrial Targeting in SARS- CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival
George B. Stefano et al.
MEDICAL SCIENCE MONITOR (2021)
Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis
Shin Jie Yong
ACS CHEMICAL NEUROSCIENCE (2021)
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies
Eleonora Calabretta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
Martina Sollini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
ASPEN lipid injectable emulsion safety recommendations part 2: Neonate and pediatric considerations
M. Petrea Cober et al.
NUTRITION IN CLINICAL PRACTICE (2021)
Cognitive impairment and a ered cerebral glucose metabolism in the subacute stage of COVID-19
Jonas A. Hosp et al.
BRAIN (2021)
About the source and consequences of 18F-FDG brain PET hypometabolism in short and long COVID-19
Igor C. Fontana et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Neurological update: COVID-19
A. L. Ren et al.
JOURNAL OF NEUROLOGY (2021)
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients
Mauro Morassi et al.
JOURNAL OF NEUROLOGY (2021)
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Ganna Blazhenets et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
Wael Al Mahmeed et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers
Edith L. Graham et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Sherry H. -Y. Chou et al.
JAMA NETWORK OPEN (2021)
Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies
Felicity Y. Han et al.
EPILEPSIA (2021)
Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides
Jia Ying Brenda Tan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Long-term neurological manifestations of COVID-19: prevalence and predictive factors
Andrea Pilotto et al.
NEUROLOGICAL SCIENCES (2021)
K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy
Natasha E. Schoeler et al.
BRAIN COMMUNICATIONS (2021)
COVID-19 and Alzheimer's Disease: A Literature Review
Louis Hardan et al.
MEDICINA-LITHUANIA (2021)
Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots
Moon Ley Tung et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2021)
The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
Ayman Iqbal et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Assessing the Impact of Factors that Influence the Ketogenic Response to Varying Doses of Medium Chain Triglyceride (MCT) Oil
Angela G. Juby et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT
Melanie Fortier et al.
ALZHEIMERS & DEMENTIA (2021)
Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4-/-: A double-blind, randomized, placebo-controlled crossover trial
Qing Xu et al.
CLINICAL NUTRITION (2020)
Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies
Konstantinos I. Avgerinos et al.
AGEING RESEARCH REVIEWS (2020)
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Yan-Chao Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
Marc Desforges et al.
VIRUSES-BASEL (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Steroid-Responsive Encephalitis in Coronavirus Disease 2019
Andrea Pilotto et al.
ANNALS OF NEUROLOGY (2020)
COVID-19 infection may cause ketosis and ketoacidosis
Juyi Li et al.
DIABETES OBESITY & METABOLISM (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Two Cases of Late-Onset Anti-NMDAr Auto-Immune Encephalitis After Herpes Simplex Virus 1 Encephalitis
Guillaume Dorcet et al.
FRONTIERS IN NEUROLOGY (2020)
The involvement of the central nervous system in patients with COVID-19
Kiarash Saleki et al.
REVIEWS IN THE NEUROSCIENCES (2020)
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
P. J. Serrano-Castro et al.
NEUROLOGIA (2020)
Neurologic Features in Severe SARS-CoV-2 Infection
Julie Helms et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis
Keshav K. Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
COVID-19 and the brain: impact on nuclear medicine in neurology
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
Ana Campos Codo et al.
CELL METABOLISM (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus
Kevin E. Wu et al.
CELL SYSTEMS (2020)
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings
C. Delorme et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
The BMJ interview: Anthony Fauci on covid-19
Fiona Godlee et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
Jeff M. P. Holly et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Nicole Jacqueline Jensen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
COVID-19 and cerebrovascular diseases: a comprehensive overview
Georgios Tsivgoulis et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Long-Term Respiratory and Neurological Sequelae of COVID-19
Fuzhou Wang et al.
MEDICAL SCIENCE MONITOR (2020)
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
Julie Helms et al.
CRITICAL CARE (2020)
Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
Asia Filatov et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Medium Chain Triglycerides Modulate the Ketogenic Effect of a Metabolic Switch
Camille Vandenberghe et al.
FRONTIERS IN NUTRITION (2020)
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M. Caprio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease
Miho Ota et al.
NEUROSCIENCE LETTERS (2019)
Astrocyte Biomarkers in Alzheimer's Disease
Stephen F. Carter et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Effects of Intermittent Fasting on Health, Aging, and Disease
Rafael de Cabo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day
Valerie St-Pierre et al.
FRONTIERS IN NUTRITION (2019)
Evidence for brain glucose dysregulation in Alzheimer's disease
Yang An et al.
ALZHEIMERS & DEMENTIA (2018)
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Jennifer C. Felger
CURRENT NEUROPHARMACOLOGY (2018)
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease
E. Croteau et al.
EXPERIMENTAL GERONTOLOGY (2018)
Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease
Etienne Croteau et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function
Shirin Hosseini et al.
JOURNAL OF NEUROSCIENCE (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Evidence for altered insulin receptor signaling in Alzheimer's disease
Chelsea M. Griffith et al.
NEUROPHARMACOLOGY (2018)
The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure
Tamara E. Lacourt et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS
Lijing Xin et al.
FRONTIERS IN NUTRITION (2018)
Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study
Alexandre Courchesne-Loyer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Cerebral Hypoperfusion and Glucose Hypometabolism: Key Pathophysiological Modulators Promote Neurodegeneration, Cognitive Impairment, and Alzheimer's Disease
Mak Adam Daulatzai
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms
Lavanya B. Achanta et al.
NEUROCHEMICAL RESEARCH (2017)
2-18F-fluoro-2-deoxyglucose positron emission tomography in delirium
Lucy R. Haggstrom et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Philipp T. Meyer et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
[18F]FDG PET signal is driven by astroglial glutamate transport
Eduardo R. Zimmer et al.
NATURE NEUROSCIENCE (2017)
Glucose utilization: still in the synapse
A. Jon Stoessl
NATURE NEUROSCIENCE (2017)
Hepatitis C virus infection, and neurological and psychiatric disorders - A review
Lydia Yarlott et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Cerebral glucose hypometabolism in Tick-Borne Encephalitis, a pilot study in 10 Patients
Anelia Dietmann et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Fatty acids and their therapeutic potential in neurological disorders
Enie Lei et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study
Tohru Ohnuma et al.
CLINICAL INTERVENTIONS IN AGING (2016)
Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease
Stephen C. Cunnane et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease
Mary T. Newport et al.
ALZHEIMERS & DEMENTIA (2015)
The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells
Sean David Hughes et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Ketone body metabolism and cardiovascular disease
David G. Cotter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
Yoshihiro Kashiwaya et al.
NEUROBIOLOGY OF AGING (2013)
Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions
Sung Min Son et al.
AUTOPHAGY (2012)
Metabolic Signatures of Insulin Resistance in 7,098 Young Adults
Peter Wurtz et al.
DIABETES (2012)
Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice
Piotr Wlaz et al.
NEUROPHARMACOLOGY (2012)
Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
Latha Devi et al.
PLOS ONE (2012)
Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity
Kendra L. Puig et al.
PLOS ONE (2012)
Brain and systemic glucose metabolism in the healthy elderly following fish oil supplementation
S. Nugent et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Marwan Maalouf et al.
BRAIN RESEARCH REVIEWS (2009)
Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia
Kathleen A. Page et al.
DIABETES (2009)
Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 Diabetes
Bhumsoo Kim et al.
ENDOCRINOLOGY (2009)
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Samuel T. Henderson et al.
NUTRITION & METABOLISM (2009)
A functional genomic fingerprint of chronic stress in humans:: Blunted glucocorticoid and increased NF-κB signaling
Gregory E. Miller et al.
BIOLOGICAL PSYCHIATRY (2008)
Anticonvulsant mechanisms of the ketogenic diet
Kristopher J. Bough et al.
EPILEPSIA (2007)
Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia
DS Lehrer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD
L Mosconi
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Effects of β-hydroxybutyrate on cognition in memory-impaired adults
MA Reger et al.
NEUROBIOLOGY OF AGING (2004)
Chronic exposure to β-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes
A Tardif et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)